相关实验视频

Updated: Jul 11, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

γδ T 细胞作为质母细胞瘤的潜在治疗剂

In Kang¹, Yumin Kim², Heung Kyu Lee^1,2

¹Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.

Frontiers in immunology

|November 6, 2023

概括

马三角形 (γδ) T 细胞显示出治疗质母细胞瘤 (GBM) 的前景. 克服瘤的微观环境

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症治疗癌症治疗

背景情况:

马三角 (γδ) T 细胞对于抗感染和抗瘤免疫是至关重要的.
质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤,通常对当前疗法有抗性.
GBM瘤微环境 (TME) 具有免疫抑制作用,阻碍了有效的免疫治疗.

研究的目的:

审查 γδ T 细胞的抗瘤功能.
讨论基于 γδ T 细胞的 GBM 免疫疗法的进步和局限性.
确定克服GBM治疗挑战的未来方向.

主要方法:

关于 γδ T 细胞和 GBM 的临床前和临床研究的文献综述.
分析瘤免疫中的 γδ T 细胞效应因子功能.
检查GBM TME特征和免疫逃避策略.

主要成果:

γδ T 细胞具有针对瘤的独特特性,包括质母细胞瘤.
目前基于 γδ T 细胞的 GBM 疗法因免疫抑制性 TME 和免疫逃避性质瘤干细胞而面临局限性.
了解γδ T细胞的作用和GBM TME抑制机制对于治疗成功至关重要.

结论:

γδ T 细胞对质母细胞瘤具有显著的治疗潜力.
需要进行进一步的研究,以克服gδ T细胞介导的GBM免疫疗法的现有局限性.
优化 γδ T 细胞疗法需要解决 GBM 瘤微环境带来的挑战.

关键词:

工程工程工程工程工程质母细胞瘤 (glioblastoma) 是一种免疫疗法免疫疗法瘤微环境是一个微环境.γδ T 细胞的 T 细胞

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.